Author

Johan E. Van Limbergen

HEAD-TO-HEAD PHARMACOKINETIC ANALYSIS OF INFLIXIMAB MONO- VS COMBINATION THERAPY IN PAEDIATRIC CROHN’S DISEASE
HEAD-TO-HEAD PHARMACOKINETIC ANALYSIS OF INFLIXIMAB MONO- VS COMBINATION THERAPY IN PAEDIATRIC CROHN’S DISEASE

Johan E. Van Limbergen  et al.

REAL-LIFE EXPERIENCE OF ANTI-DRUG ANTIBODIES AGAINST ANTI-TNF AGENTS AT TWO TERTIARY CARE PAEDIATRIC INFLAMMATORY BOWEL DISEASE CENTRES
REAL-LIFE EXPERIENCE OF ANTI-DRUG ANTIBODIES AGAINST ANTI-TNF AGENTS AT TWO TERTIARY CARE PAEDIATRIC INFLAMMATORY BOWEL DISEASE CENTRES

Johan E. Van Limbergen  et al.

TRYPTOPHAN METABOLITE CHANGES WITH DIET-INDUCED REMISSION IN PEDIATRIC CROHN’S DISEASE
TRYPTOPHAN METABOLITE CHANGES WITH DIET-INDUCED REMISSION IN PEDIATRIC CROHN’S DISEASE

Johan E. Van Limbergen  et al.

PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU
PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU

Johan E. Van Limbergen  et al.

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition
Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition

Johan E. Van Limbergen  et al.

Item 1 - 5 / 5
1